Replimune (REPL) Accumulated Expenses (2018 - 2026)

At the end of FY2026 (ended Mar 31, 2026), Replimune's Accumulated Expenses came in at $47.52 million, up 3.5% from FY2025.

• Annual Accumulated Expenses has increased for seven consecutive fiscal years, with a five-year compound annual growth rate of 40.3% (FY2021 to FY2026).
• In prior fiscal years, Replimune's Accumulated Expenses was $45.92 million in FY2025 (+35.1%), $33.98 million in FY2024 (+37.6%), $24.7 million in FY2023 (+84.5%) and $13.39 million in FY2022 (+53.3%).
• The fiscal Q1 2027 figure stands as the lowest quarterly Accumulated Expenses since fiscal Q1 2024.
• On a year-over-year basis, Accumulated Expenses increased in six of the last eight quarters, with growth averaging 13.3%.
• The strongest year-over-year quarter for Accumulated Expenses in the past five years was fiscal Q2 2024, with growth of 98.6%; the weakest was fiscal Q1 2027, with a decline of 24.8%.
• According to Business Quant data, Accumulated Expenses for the three prior fiscal quarters was $47.52 million (Q4 2026), $40.37 million (Q3 2026) and $42.45 million (Q2 2026).